Incremental Value of Fusion Imaging With Integrated PET-CT in Oncology

Purpose: The purpose of this study was to assess the incremental value of integrated F-18 FDG PET-CT imaging compared with either alone for evaluation of patients with body malignancies. Materials and Methods: Images from 173 consecutive patients with body malignancies referred for integrated PET-CT imaging were reviewed. A CT with contrast performed within 2 months of PET-CT was available for 74 patients. Results: There was agreement between the transmission CT (TrCT) and PET interpreted separately in 65% (112 of 173) of patients. Interpretation of integrated PET-CT had an incremental diagnostic value in 17.9% (31 of 173) of the total patient population. Data was analyzed further excluding patients for whom further analysis was not relevant: 1) 20% (34 of 173) of patients with normal TrCT and PET and 2) 11% (19 of 173) of patients with disseminated metastases (too numerous to count) on both TrCT and PET. Among the 120 other patients, PET interpreted alone was positive in 195 body regions and CT-positive in 178 body regions with agreement for all regions in 49% (59 of 120) of patients and discordance or equivocal lesions in 51% (61 of 120) of patients. Integrated PET-CT had an incremental diagnostic value in 27% (31 of 120) of patients. Contrasted CT scan demonstrated hepatic lesions in 5 and extrahepatic lesions in 3 patients overlooked on TrCT; all 8 of these lesions were PET-positive. There was incremental impact on the management of 12.5% (15 of 120) of patients. Conclusions: After excluding patients with a normal PET-CT or disseminated disease, there was an incremental diagnostic value of integrated PET-CT imaging in 27% (31 of 120) and incremental impact on management in 12.5% (15 of 120) of patients. CT with contrast did not demonstrate lesions not appreciated by PET-CT.

[1]  R. Hustinx,et al.  Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[3]  Thomas Beyer,et al.  PET/CT scanners: a hardware approach to image fusion. , 2003, Seminars in nuclear medicine.

[4]  W. Martin,et al.  Practical FDG Imaging: A Teaching File , 2002, Springer New York.

[5]  M. Braun,et al.  Software for image registration: algorithms, accuracy, efficacy. , 2003, Seminars in nuclear medicine.

[6]  R. Wahl,et al.  Initial experience with oral contrast in PET/CT: phantom and clinical studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  A. Buck,et al.  Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Richard L Wahl,et al.  Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements. , 2003, Seminars in nuclear medicine.

[9]  Richard L Wahl,et al.  Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Tomio Inoue,et al.  Image Fusion System Using PACS for MRI, CT, and PET Images. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[11]  L. Shah,et al.  Positron Emission Tomography/Computed Tomography Fusion Imaging in Brown Adipose Tissue , 2004, Clinical nuclear medicine.

[12]  Cyrill Burger,et al.  Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  W. Weber Brown adipose tissue and nuclear medicine imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  P. Valk,et al.  PET and PET/CT Imaging in Colorectal Cancer , 2006 .

[15]  R. Wahl,et al.  Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma , 2003 .

[16]  Cyrill Burger,et al.  Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion -- report of six cases. , 2002, Radiology.

[17]  F. Grünwald,et al.  Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphoma. , 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[18]  Mithat Gonen,et al.  Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  R. Wahl,et al.  Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  C. Meltzer,et al.  Image Analysis in Patients with Cancer Studied with a Combined PET and CT Scanner , 2000, Clinical nuclear medicine.

[21]  M P Sandler,et al.  Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps. , 2001, Radiology.

[22]  G. Gladish,et al.  Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. , 2004, AJR. American journal of roentgenology.

[23]  D W. Townsend,et al.  Combined PET/CT Imaging in Oncology. Impact on Patient Management. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[24]  Townsend,et al.  7. Survey of Results of Whole Body Imaging Using the PET/CT at the University of Pittsburgh Medical Center PET Facility. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[25]  I. Fogelman,et al.  Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. , 1996, Seminars in nuclear medicine.

[26]  A. Kuten,et al.  Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.